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often requires ureteroscopy or laparoscopy. The prognosis 
of ureteral endometriosis depends on the time of diagnosis. 
In too many cases of bilateral obstruction, the patient is re-
ferred to the nephrologist because of an advanced, irrevers-
ible renal failure. Although some patients may benefit from 
progestin or anti-arotamase therapy, in most cases of ure-
teral endometriosis surgery is needed, laparoscopy surgery 
being preferred today to laparatomy. 
 Copyright © 2009 S. Karger AG, Basel 
 Introduction and Overview 
 Very little has been reported in the nephrological lit-
erature on the possibility that ureteral endometriosis may 
lead to end-stage renal disease (ESRD). The true inci-
dence of ureteral endometriosis is still unknown, but its 
association with renal obstruction is well recognized. 
The main problem is that bilateral ureteral endometriosis 
may be asymptomatic and many cases are discovered in-
cidentally during laparoscopy for extensive endometri-
osis. On the other hand, while renal echography may 
show a pyelocaliceal dilation in cases of extraureteral en-
dometriosis it is of little, if any, help for diagnosing pa-
tients with endoureteral endometriosis. Recent observa-
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 Abstract 
 Little attention has been paid by the renal literature to ure-
teral endometriosis, a rare and silent disorder that can even-
tually lead to renal failure. In endometriosis, the ureteral in-
volvement can be limited to a single ureter, more often the 
left one, or both ureters with consequent urine tract ob-
struction and ureterohydronephrosis. In most cases, the ure-
teral obstruction is caused by endometrial tissue surround-
ing the ureter (extrinsic ureteral endometriosis). In the re-
maining cases, endometrial cells are located within the 
ureter (intrinsic ureteral endometriosis). Progressive ureteral 
obstruction can be insidious in onset and can ultimately lead 
to renal failure if a correct diagnosis is missed. The true inci-
dence of renal failure caused by endometriosis is complete-
ly unknown, although cases have been reported in the lit-
erature. The diagnosis of ureteral endometriosis is difficult 
since the disease may be clinically silent or associated with 
non-specific symptoms. Only a high index of suspicion and 
radiological support may help to obtain an early diagnosis. 
However, while renal imaging is useful in the cases of extrin-
sic endometriosis, the diagnosis of intrinsic endometriosis 
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tion of 2 cases of young women with a history of pelvic 
endometriosis progressing to ESRD without any suspi-
cion of the possible association from their nephrologists, 
prompted us to review the available data concerning ure-
teral endometriosis and ESRD.
 Endometriosis is a clinical disorder in which function-
ally active endometrial cells are deposited in areas outside 
the uterus. The disorder is typically seen during the re-
productive years occurring in 5–15% of women and is 
more common in nulliparous or infertile women. The 
pelvis is the main location of the endometrial tissue, how-
ever, extrapelvic locations have been found in lung, lymph 
nodes, scars, and, exceptionally, in the kidney  [1, 2] . 
Symptoms depend on the site of implantation. Chronic 
pelvic pain more or less related to menses, dyspareunia 
and dysuria are frequent manifestations but can also be 
seen in other diseases. Extragenital endometriosis rarely 
involves the urinary apparatus, however, when it does
occur, involvement of the bladder, ureter, kidney and ure-
thra is 85, 10, 4, and 2%, respectively  [3] . Ureters are rare-
ly involved in endometriosis, however, the close anatom-
ical proximity of the distal ureter to the female reproduc-
tive organs makes it an ideal target for the development 
of extrinsic compression of the ureter  [4] . Deeply infil-
trating endometriosis of the pelvis is often asymmetric 
and mainly involves the left pelvis: it may cause recto-
vaginal lesions and can involve other vital structures, in-
cluding the bladder and ureters. When within the blad-
der, the lesion is usually situated in the posterior wall or 
at the dome; more rarely endometrial lesions involve the 
vesical base being proximal to ureteral hiatus. Ureteral 
endometriosis is classified as intrinsic and extrinsic with 
a 1: 4 ratio and the ureter is usually involved below the 
pelvis brim  [5, 6] .
 The ureteral involvement may lead to urine tract ob-
struction and ureterohydronephrosis which can happen 
with minimal or extensive disease. Involvement can be 
limited to a single ureter, more often the left one  [7] , or 
both ureters, particularly in patients with extensive pel-
vic endometriosis. Ureteral endometriosis is usually 
discovered in women aged between 30 and 35 years  [4, 
7–9] . It is uncommon and therefore even more likely to 
remain undiagnosed in postmenopausal women  [10] . In 
the extrinsic form (about 75% of all cases), ureteral en-
dometriosis is localized to the adventitia or surrounding 
connective tissue of the ureter. Pathologic and clinical 
studies report that most patients showed hydroureter 
hydronephrosis, with superimposed pyelonephritis in 
about one third of cases  [11] . As many as 25–50% of 
nephrons are lost when ureteral endometriosis is pres-
ent. Rare cases of renal failure caused by bilateral ure-
teral obstruction have been reported  [12] but the true 
incidence of ESRD caused by endometriosis is com-
pletely unknown.
 Pathogenesis 
 The pathogenesis of deeply infiltrating endometriosis 
is still under discussion. A first hypothesis was that pelvic 
endometriosis might be a direct extension of endome-
trial cells outside the uterine wall favored by previous pel-
vic surgery  [13] . This interpretation was supported by the 
fact that the diagnosis of ureteral endometriosis is pre-
ceded in most cases by hysterectomy and bilateral sal-
pingo-oophorectomy, possibly because of prior symp-
toms related to adenomyosis or pelvic endometriosis, and 
that ureteral endometriosis has a strong predilection for 
involvement of the lower third of the left ureter. However, 
the available evidence rather suggests that deep infiltrat-
ing vesical and rectovaginal endometriosis result from 
intraperitoneal seeding of regurgitated endometrial cells, 
which collect and implant in the most dependent por-
tions of the peritoneal cavity and the anterior and poste-
rior cul-de-sac, and trigger an inflammatory process 
leading to adhesion of contiguous organs with creation of 
false peritoneal bottoms. Peritoneal, ovarian, and deep 
endometriosis may be diverse manifestations of a disease 
caused by regurgitated endometrium. According to these 
findings, the occurrence of ureteral endometriosis may 
be explained by the menstrual reflux theory with flow of 
peritoneal fluid and by the anatomic differences of the 
left and right hemipelvis  [14] . However, further data are 
needed to demonstrate the validity and reliability of this 
hypothesis  [15] .
 Clinical Presentation 
 The clinical presentation of ureteral endometriosis 
may be variable. In most cases the disease is clinically 
silent  [9] . In about one third of patients ureteral endo-
metriosis is associated with non-specific symptoms 
such as dysmenorrhea, dyspareunia, pelvic pain, infer-
tility, dysuria, frequency, recurrent urinary tract infec-
tions, or lumbar pain  [16] . In women with chronic pelvic 
non-cyclic pain, the occurrence of endometriosis must 
be taken into account. In the differential diagnosis, the 
postoperative adhesions, pelvic varices, interstitial cys-
titis and irritable bowel syndrome must be considered 
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 [17] . A correlation between pain occurrence and uterine 
cyclic phase has not been clearly demonstrated. Hema-
turia is rare. Rarely, ureteral endometriosis is present 
with right lower quadrant pain giving rise to initial di-
agnostic possibility of acute appendicitis  [18] . In rare 
cases the disease may present with arterial hypertension 
 [19] or acute renal failure  [20, 21] . In most cases ureteral 
endometriosis is not associated with bladder disease, 
however, it is often associated with retrocervical and 
rectum-sigmoid lesions  [22] . For patients with associ-
ated ovarian endometrioma, deeply infiltrating endo-
metrial lesions are more severe, with an increased rate 
of vaginal, intestinal, and ureteral lesions. About 30% of 
patients suffer from reduced kidney function at the time 
of diagnosis  [11] . For the nephrologist it is important to 
recall that an undefined number of women silently 
progress to advanced renal failure due to bilateral ob-
structive uropathy. In other cases the loss of one kidney 
is discovered incidentally.
 Diagnosis 
 Progressive ureteral obstruction can be insidious in 
onset and can ultimately lead to renal failure. The diag-
nosis of ureteral endometriosis should be considered in 
women with renal symptoms of non-calculous obstruc-
tion, particularly in premenopausal women with an an-
amnesis of polycystic ovary disease or severe menstrual 
related symptoms, although the disease is often strictly 
associated with silent renal obstruction. The diagnosis 
of ureteral endometriosis is difficult. Since endometrio-
sis rarely involves mucosal membranes, exfoliative cy-
tology is only occasionally able to detect endometrial 
and glandular cells in the urine  [23] . Only a high index 
of suspicion and radiological support may help to obtain 
an early diagnosis. In one study, ureteral endometriosis 
was presumptively diagnosed before surgery only in 
40% of patients  [9] . Imaging techniques are of limited 
value in providing an accurate depiction of extension of 
ureteral lesions. Abdominal ultrasonography may raise 
suspicion that could be confirmed by further investiga-
tions. However, not in all women with ureteral endome-
triosis echography shows ureteral or calicopyelic dila-
tion. Intrinsic ureteral endometriosis can lead to uni-
lateral renal atrophy without dilatation. Extensive 
unresectable periureteral fibroinflammatory thicken-
ing involving vascular or visceral structures may be as-
sociated with mild or absent dilatation. In other in-
stances, ultrasonography may show moderate calico py-
elic dilatation that can be confused with parapyelic cysts 
or sponge kidneys.
 Intravenous urography and, more recently, spiral com-
puted tomography still remain important diagnostic 
tools for ureteral endometriosis, as they may localize the 
level, degree and laterality of ureteral involvement. How-
ever, urography is unable to identify the cause of an ex-
trinsic obstruction. In the case of intrinsic endometriosis, 
urography may show a filling defect within the lumen of 
the ureter, but again this finding is not specific as it can 
be caused by stones or transitional cell cancer.
 Magnetic resonance imaging (MRI) is sensitive and 
specific, although the ureteral lesions may be underes-
timated  [24] . Magnetic resonance urography is accurate 
in differentiating between intrinsic and extrinsic forms 
of ureteral involvement  [25] . Ureteral endometriosis can 
be identified as a hypointense nodule on T 2 -weighted 
images and hyperintense foci on T 1 -weighted images. 
MRI can also detect periureteral involvement (extrinsic 
endometriosis) rather than ureteral wall lesions (intrin-
sic endometriosis). MRI is also a useful preoperative 
tool for directing towards better treatment  [26] . Some-
times, diagnostic imaging may lead to some pitfalls. For 
example, radiographs may show ‘pulmonary metasta-
ses’ together with hydronephrosis, mimicking a malig-
nant metastatic gynecologic tumor of unknown prima-
ry origin  [27] .
 Ureteroscopy is particularly useful to discover intrin-
sic endometriosis  [5, 28] . A diagnostic tool often used for 
evaluation of a wide range of abnormalities, including 
ureteropelvic junction obstructions, ureteral and renal 
pelvic neoplasms, and obstructed ureter is two-dimen-
sional endoluminal sonographic imaging of the ureter. It 
can demonstrate the periureteral anatomy, and can de-
fine the presence and the nature of lesions within the ure-
teral wall. Three-dimensional reconstruction of two-di-
mensional sonographic imaging is a new technique ap-
plicable to intraluminal imaging. It offers advantages 
over two-dimensional imaging by demonstrating the 
spatial relation of anatomic structures that cannot be ap-
preciated using conventional imaging  [29] .
 Laparoscopy allows direct localization of endometrial 
tissue around the ureter while its role in patients with in-
trinsic endometriosis is limited. Because the inflamma-
tory process surrounding endometrial tissue is in close 
proximity to the ureter, adequate visualization of the ure-
ter for proper diagnosis may require aggressive mobiliza-
tion of the colon and ureter. The main advantage of lapa-
roscopy – as a diagnostic tool – is to identify other foci of 
endoperitoneal endometriosis, especially in the region of 
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the cul-de-sac. Laparoscopic adhesiolysis, ureteroureter-
ostomy or ureteral reimplantation, although technically 
challenging, can be performed  [5] .
 Ureteral endometriosis should be included in the dif-
ferential diagnosis of obstructive ureteral lesions in wom-
en, particularly those involving the lower third of the left 
ureter, even in postmenopausal patients. The nature of 
invasive tissue may be confirmed by immunostains for 
cytokeratin-7 (CK7) and progesterone receptor (PR) 
which are positive in case of endometriosis, whereas im-
munostains for estrogen receptor (ER) are positive in 83% 
of cases and immunostains for CK20 are negative in all 
cases. CA125 immunostains are positive in 67% of cases. 
The stromal cells are positive for CD10, ER, and PR im-
munostaining  [30] . Polypoid endometriosis is a rare 
manifestation of endometriosis that may be mistaken for 
a neoplasm on clinical, intraoperative, or pathologic as-
sessment  [31] .
 Outcome and Prognosis 
 The prognosis of kidney endometriosis is generally 
good  [1, 2] . A single case of a large endometriotic cyst, 
arising from the left renal area and occupying almost the 
whole left side of the abdomen, has been reported  [32] . 
The prognosis of ureteral endometriosis depends on the 
time of diagnosis. In too many cases of bilateral obstruc-
tion, often secondary to pelvic surgery, the clinical pre-
sentation is characterized by an advanced renal failure 
and shrunken kidneys or dilated kidneys with extremely 
thin cortices at ultrasonography. In case of an early diag-
nosis, an appropriate medical or surgical treatment may 
prevent renal function deterioration. However, recur-
rence can occur. Out of 30 patients with ureteral endo-
metriosis treated with ureterolyis, ureter resection or 
ureterectomy and ureterocystotomy during a mean fol-
low-up period of 14.6 months endometriosis recurred in 
3 patients with no evidence of ureteral reinvolvement 
 [9] .
 Treatment 
 Drugs induce temporary quiescence of active endome-
trial deep lesions and may be useful in selected circum-
stances. Progestins should be considered as first-line 
medical treatment for temporary pain relief. Hormone 
therapy should be offered to patients of childbearing age 
who have the disease at an early stage and wish to have 
children. The aromatase inhibitor anastrozole which 
blocks conversion of aromatizable steroids to estrogen 
has also been used, but not all patients respond to this 
treatment  [33] . Ureteral lesions secondary to endometri-
osis can be treated by cystoscopy and JJ stent  [34] . How-
ever, in most cases of severely infiltrating disease, surgery 
is the final solution, particularly in case of intrinsic ure-
teral obstruction  [11] .
 Surgical treatment may consist of ureteroneocystos-
tomy, laparoscopic ureterolysis, with later ureteral resec-
tion and end-to-end anastomosis, or even autotrans-
plantation in case of ureteral relapses. Traditionally, lap-
arotomy has been the method of choice for ureteral in-
juries even when the injury is identified during a lapa-
roscopic procedure. Today, however, some urologists
feel that laparotomy should be avoided  [34] as it shows a 
higher rate of infection and incisional hernias, longer 
hospital stay, and slower recovery compared with lapa-
roscopy. It is still debated whether segmental resection 
and anastomosis or ureterolysis or minimal-access pro-
cedures are preferable. Recent studies suggest that lapa-
roscopic ureterolysis can be an effective treatment op-
tion in most patients with ureteral endometriosis but 
that recurrence rates are not negligible  [9] . Successful ap-
plication of laparoscopic surgery, even for procedures 
that have traditionally necessitated laparotomy, has been 
reported. Extensive experience with endourological 
techniques is prerequisite for success  [35] . Systematic 
ureteric stenting prior to surgical dissection of the pelvic 
wall is recommended in patients with posterior nodules 
and in the case of partial cystectomy for anterior nodules 
when the ureteric meati are adjacent to the lesion. Ure-
teric reimplantation onto a psoas hitch bladder must be 
performed when the endometrial lesions are extensive 
and partly resected or invade the ureteric wall. The fre-
quency of associated lesions (urinary, gynecological gas-
trointestinal) justifies a multidisciplinary surgical ap-
proach  [36] .
 Conclusions 
 Urinary tract endometriosis is an uncommon patho-
logic finding and a silent cause of monolateral or bilat-
eral renal atrophy in an undefined number of patients. 
The nephrologist should carefully monitor renal func-
tion and renal ultrasonography in patients with a diagno-
sis of endometriosis. In patients with signs of dilation or 
hyperechogenicity at ultrasonography and/or signs of re-
nal dysfunction, MRI and ureteroscopy may be indicat-
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ed. Patients with previous pelvic surgery because of deep-
ly infiltrating endometriosis are at high risk of ureteral 
endometriosis and should be carefully investigated and 
monitored over time. The upper urinary tract should be 
evaluated in patients with severe endometriosis, even in 
postmenopausal women. Surgery is the treatment of 
choice. Conservative laparoscopic surgery is a safe, fea-
sible modality for management of ureteral endometri-
osis. However, the surgical technique depends on the lo-
cation and depth of the lesion. As a form of adjuvant 
treatment to surgery, hormonal therapy is an appropriate 
option.
 
 References 
 1 Dutta P, Bhat MH, Bhansali A, Kumar V: A 
young woman with endometriosis of kidney. 
Saudi Med J 2006; 27: 244–246. 
 2 Rousselot F, Liard-Meillon ME: Renal endo-
metriosis. Report of one case. Prog Urol 
1996; 6: 936–939. 
 3 Abeshouse BS, Abeshouse G: Endometriosis 
of the urinary tract. J Int Coll Surg 1960; 4: 
 43–63. 
 4 Yohannes P: Ureteral endometriosis. J Urol 
2003; 170: 20–25. 
 5 Generao SE, Keene KD, Das S: Endoscopic 
diagnosis and management of ureteral endo-
metriosis. J Endourol 2005; 19: 1177–1179. 
 6 Pérez M, Aguilera Bazán A, Alonso Dorrego 
JM, Hernández A, de Francisco MG, Martín 
Hernández M, de Santiago J, de la Peña Bar-
thel J: Urinary tract endometriosis: clinical, 
diagnostic, and therapeutic aspects. Urology 
2009; 73: 47–51. 
 7 Chapron C, Chopin N, Borghese B, Foulot H, 
Dousset B, Vacher-Lavenu MC, Vieira M, 
Hasan W, Bricou A: Deeply infiltrating en-
dometriosis: pathogenetic implications of 
the anatomical distribution. Hum Reprod 
2006; 21: 1839–1845. 
 8 Frenna V, Santos L, Ohana E, Bailey C, Wat-
tiez A: Laparoscopic management of ureteral 
endometriosis: our experience. J Minim In-
vasive Gynecol 2007; 14: 169–171. 
 9 Seracchioli R, Mabrouk M, Manuzzi L, Guer-
rini M, Villa G, Montanari G, Fabbri E, Ven-
turoli S: Importance of retroperitoneal ure-
teric evaluation in cases of deep infiltrating 
endometriosis. J Minim Invasive Gynecol 
2008; 15: 435–439. 
 10 Pugliese JM, Peterson AC, Philbrick JH Jr, 
Allen RC Jr: Ureteral endometriosis in pa-
tients after total abdominal hysterectomy: 
presentation and diagnosis: a case series. 
Urology 2006; 67: 622. 
 11 Horn LC, Do Minh M, Stilzenburg JU: In-
trinsic form of ureteral endometeriosis caus-
ing ureteral obstruction and partial loss of 
kidney function. Urol Int 2004; 73: 181–184. 
 12 Comiter CV: Endometriosis of the urinary 
tract. Urol Clin North Am 2002; 29: 625–
635. 
 13 Stillwell TJ, Kramer SA, Lee RA: Endome-
triosis of ureter. Urology 1986; 28: 81–85. 
 14 Vercellini P, Pisacreta A, Pesole A, Vicentini 
S, Stellato G, Crosignani PG: Is ureteral en-
dometriosis an asymmetric disease? BJOG 
2000; 107: 559–561. 
 15 Vercellini P, Frontino G, Pietropaolo G, Gat-
tei U, Daguati R, Crosignani PG: Deep endo-
metriosis: definition, pathogenesis, and clin-
ical management. J Am Assoc Gynecol 
Laparosc 2004; 11: 153–161. 
 16 Stamatiou K, Petrakos G, Alevizos A, Bovis 
K, Economou A, Panagopoulos P, Mariolis 
A: Endometriosis of ureter-induced recur-
rent urinary tract infections in a premeno-
pausal woman – case report. Clin Exp Obstet 
Gynecol 2007; 34: 63–64. 
 17 Vercellini P, Somigliana E, Viganò P, Abbia-
ti A, Barbara G, Fedele L: Chronic pelvic pain 
in women: etiology, pathogenesis and diag-
nostic approach. Gynecol Endocrinol 2009; 
 25: 149–158. 
 18 Giri SK, Long RM, Barry D, Flood HD, Mo-
ran KT: Ureteral endometriosis and ovarian 
mucinous cystadenoma presenting with 
acute pyonephrosis. Ir J Med Sci 2005; 174: 
 67–70. 
 19 Aldington S, Gujral S, Sibley GN: Reversible 
hypertension in a young female: ureteric ob-
struction due to endometriosis. Int J Clin 
Pract 2002; 56: 552–553. 
 20 Gagnon RF, Arsenault D, Pichette V, Tan-
guay S: Acute renal failure in a young woman 
with endometriosis. Nephrol Dial Trans-
plant 2001; 16: 1499–1502. 
 21 Akçay A, Altun B, Usalan C, Ulusoy S, Er-
dem Y, Yasavul U, Turgan C, Caglar S: Cycli-
cal acute renal failure due to bilateral ure-
teral endometriosis. Clin Nephrol 1999; 52: 
 179–182. 
 22 Abrão MS, Podgaec S, Dias JA Jr, Averbach 
M, Silva LF, Marino de Carvalho F: Endome-
triosis lesions that compromise the rectum 
deeper than the inner muscularis layer have 
more than 40% of the circumference of the 
rectum affected by the disease. J Minim In-
vasive Gynecol 2008; 15: 280–285. 
 23 Schneider V, Smith MJ, Frable WJ: Urinary 
cytology in endometriosis of the bladder. 
Acta Cytol 1980; 24: 30–33. 
 24 Balleyguier C: Imaging features of endome-
triosis. J Gynecol Obstet Biol Reprod (Paris) 
2003; 32: 85–100. 
 25 Ghezzi F, Cromi A, Bergamini V, Bolis P: 
Management of ureteral endometriosis: ar-
eas of controversy. Curr Opin Obstet Gyne-
col 2007; 19: 319–324. 
 26 Balleyguier C, Roupret M, Nguyen T, Kinkel 
K, Helenon O, Chapron C: Ureteral endome-
triosis: the role of magnetic resonance imag-
ing. J Am Assoc Gynecol Laparosc 2004; 11: 
 530–536. 
 27 Ludwig M, Bauer O, Wiedemann GJ, Died-
rich K: Ureteric and pulmonary endometri-
osis. Arch Gynecol Obstet 2001; 265: 158–
161. 
 28 Zanetta G, Webb MJ, Segura JW: Ureteral 
endometriosis diagnosed at ureteroscopy. 
Obstet Gynecol 1998; 91: 857–859. 
 29 Grotas A, Grasso M: Endoluminal sono-
graphic imaging of upper urinary tract: 
three-dimensional reconstruction. J Endo-
urol 2001; 15: 485–488. 
 30 Al-Khawaja M, Tan PH, MacLennan GT, Lo-
pez-Beltran A, Montironi R, Cheng L: Ure-
teral endometriosis: clinicopathological and 
immunohistochemical study of 7 cases. Hum 
Pathol 2008; 39: 954–959. 
 31 Parker RL, Dadmanesh F, Young RH, Clem-
ent PB: Polypoid endometriosis: a clinico-
pathologic analysis of 24 cases and a review 
of the literature. Am J Surg Pathol 2004; 28: 
 285–297. 
 32 Yaqub U, Hassan SE, Yusaf Z, Yusuf AW: En-
dometriosis in the renal area. J Coll Physi-
cians Surg Pak 2008; 18: 174–175. 
 33 Bohrer J, Chen CC, Falcone T: Persistent bi-
lateral ureteral obstruction secondary to en-
dometriosis despite treatment with an aro-
matase inhibitor. Fertil Steril 2008; 90: 2004.
e7–2004.e9. 
 34 Weingertner AS, Rodriguez B, Ziane A, Gi-
bon E, Thoma V, Osario F, Haddad C, Wat-
tiez A: The use of JJ stent in the management 
of deep endometriosis lesion, affecting or 
potentially affecting the ureter: a review of 
our practice. BJOG 2008; 115: 1159–1164. 
 35 Ghezzi F, Cromi A, Bergamini V, Serati M, 
Sacco A, Mueller MD: Outcome of laparo-
scopic ureterolysis for ureteral endometri-
osis. Fertil Steril 2006; 86: 418–422. 
 36 Marcelli F, Collinet P, Vinatier D, Robert Y, 
Triboulet JP, Biserte J, Villers A: Ureteric and 
bladder involvement of deep pelvic endome-
triosis. Value of multidisciplinary surgical 
management. Prog Urol 2006; 16: 588–593. 
 
 Ponticelli /Graziani /Montanari Nephron Clin Pract 2010;114:c89–c94c94
 This intriguing editorial draws the nephrologist’s at-
tention to an unusual cause of ureteric obstruction and 
hydronephrosis in premenopausal women, namely ure-
teric endometriosis. It provides the reader with clues to 
diagnosis and recommends a high index of suspicion in 
those at risk. It also provides comprehensive monitoring, 
diagnostic and management recommendations. Most of 
all, this minireview points to an uncommon and proba-
bly underdiagnosed cause of ureteric obstruction in 
young women. Those who have come across similar cas-
es are encouraged to report them to  Nephron .
 
 Editorial Comment 
 M. El Nahas, Sheffield 
